The AHA today expressed serious concerns with the Centers for Medicare & Medicaid Services’ proposal to significantly reduce the payment rate for “nonexcepted” services provided in off-campus provider-based departments under the physician fee schedule proposed rule for calendar year 2018. “Making such an adjustment in CY 2018 would be arbitrary and capricious, unreasonable and unsupported by existing data, and in violation of the Administrative Procedure Act,” wrote AHA Executive Vice President Tom Nickels. AHA also expressed concern that the data CMS will use to calculate 2018 payment rates for the clinical lab fee schedule under the proposed rule are unreliable and incomplete. “Given the expected Jan. 1, 2018 timeframe for implementing the new CLFS payment rates, we urge the agency to take immediate steps, outlined in our detailed comments, to address these concerns,” AHA said. Among other comments, the association expressed support for the agency’s proposals to add new codes to its list of approved Medicare telehealth services and to delay the appropriate use criteria requirements.

Related News Articles

Headline
Rep. Brett Guthrie, R-Ky., today addressed attendees of AHA’s 2024 Annual Membership Meeting and touched on many of the biggest issues in health care:…
Headline
The Change Healthcare cyberattack was a significant event that caught many off guard, said the Centers for Medicare & Medicaid Services Administrator…
Headline
The voluntary Episode Quality Improvement Program for specialist physicians saved Medicare $20 million in its first year, the Maryland Health Services Cost…
Headline
Commenting April 12 on a proposed rule to strengthen oversight of accrediting organizations, AHA told the Centers for Medicare & Medicaid Services it…
Headline
For future public health emergencies, the Centers for Medicare & Medicaid Services should improve how it sets Medicare rates for clinical diagnostic…
Headline
The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug programs for contract year 2025…